Hear from Paul Biondi, President of Pioneering Medicines and Executive Partner, »Æ¹ÏÊÓƵapp, and Uli Stilz, Vice President, Novo Nordisk Bio Innovation Hub, on a new partnership bringing together Flagship’s ecosystem of first-in-category bioplatforms with the disease expertise of Novo Nordisk, to jointly create a portfolio of transformational medicines.
More from:
Human Health
Three Questions with Hari Pujar, Founding President of Mirai Bio and Flagship Operating Partner
The Next Generation of Biologics Are Supranatural
Three Questions with Volker Herrmann, Flagship CEO-Partner & CEO of Sonata Therapeutics
Pioneering Profile
Q&A with Molly Gibson on Leading Company Origination
Letter of Support